MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis
NCT ID: NCT01368913
Last Updated: 2013-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
138 participants
OBSERVATIONAL
2011-06-30
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Minirin Melt® in Adult Patients With Nocturia
NCT03089073
A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
NCT00209261
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
NCT04329975
Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
NCT01184859
Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients
NCT01262456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients treated with orally disintegrating tablet
No interventions assigned to this group
Patients treated with tablets
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients and their parents have been informed about the study and have given their written consent for participation.
Exclusion Criteria
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ferring Arzneimittel GmbH
INDUSTRY
Ferring Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Development Support
Role: STUDY_DIRECTOR
Ferring Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Investigational Site , An der Ziegelei 8
Bonn, , Germany
Investigational Site
Bad Bergzaben, , Germany
Investigational Site, Kaiserdamm 26
Berlin, , Germany
Investigational Site, Mahlsdorfer Straße 39-40
Berlin, , Germany
Investigational Site, Neckarstrasse 7
Berlin, , Germany
Investigational Site, Potsdamer Chussee 80
Berlin, , Germany
Investigational Site
Bingen, , Germany
Investigational Site, Zossener Damm 42
Blankenfelde, , Germany
Investigational Site, Reichsstraße 51
Bonn, , Germany
Investigational Site
Brackenheim, , Germany
Investigational Site
Brunsbüttel, , Germany
Investigational Site
Cologne, , Germany
Investigational Site
Crailsheim, , Germany
Investigational Site
Dresden, , Germany
Investigational Site
Duisburg, , Germany
Investigational Site, Suitberutsstraße 31
Düsseldorf, , Germany
Investigational Site, Westfalenstraße 26
Düsseldorf, , Germany
Investigational Site
Düsseldorf, , Germany
Investigational Site
Erfurt, , Germany
Investigational Site
Espelkamp, , Germany
Investigational Site
Ettenheim, , Germany
Investigational Site
Forchheim, , Germany
Investigational Site
Frankfurt am Main, , Germany
Investigational Site
Friedberg, , Germany
Investigational Site
Fulda, , Germany
Investigational Site
Gelsenkirchen, , Germany
Investigational Site
Germering, , Germany
Investigational Site
Gernsbach, , Germany
Investigational Site
Gilching, , Germany
Investigational Site
Görlitz, , Germany
Investigational Site
Groß-Umstadt, , Germany
Investigational Site
Großenhain, , Germany
Investigational Site
Großröhrsdorf, , Germany
Investigational Site
Hammelburg, , Germany
Investigational Site
Hanover, , Germany
Investigational Site
Harsewinkel-Greffen, , Germany
Investigational Site
Homburg/Saar, , Germany
Investigational Site
Hürth, , Germany
Investigational Site
Hüttenberg, , Germany
Investigational Site
Itzehoe, , Germany
Investigational Site
Karlsruhe, , Germany
Medical Faculty of University Clinic - Schwanenweg 20
Kiel, , Germany
Investigational Site
Königswinter-Oberpl., , Germany
Investigational Site, Neue Linner Straße 77
Krefeld, , Germany
Investigational Site
Langerwehe, , Germany
Investigational Site
Lehrte, , Germany
Investigational Site
Lengerich, , Germany
Investigational Site
Leverkusen-Schlebusch, , Germany
Investigational Site
Minden, , Germany
Investigational Site
Mönchengladbach, , Germany
Investigational Site
Mutzschen, , Germany
Investigational Site
Neu Wulmstorf, , Germany
Investigational Site
Neumünster, , Germany
Investigational Site
Oberhausen, , Germany
Investigational Site
Oederan, , Germany
Investigational Site, Waldstraße 43
Offenbach, , Germany
Investigational Site
Offenbach, , Germany
Investigational Site
Oldenburg, , Germany
Investigational Site
Ottobrunn bei München, , Germany
Investigational Site
Potsdam, , Germany
Investigational Site
Rothenburg, , Germany
Investigational Site
Rottweil, , Germany
Investigational Site
Rüsselsheim am Main, , Germany
Investigational Site
Schopfheim, , Germany
Investigational Site
Schwabach, , Germany
Investigational Site
Strausberg, , Germany
Investigational Site
Traunstein, , Germany
Investigational Site
Trittau, , Germany
Investigational Site
Varel, , Germany
Investigational Site
Wertheim am Main, , Germany
Investigational Site
Wiefelstede, , Germany
Investigational Site
Wilkau-Haßlau, , Germany
Investigational Site
Wuppertal, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.